Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis
Philippe Gevaert(Ghent University), Nicholas Van Bruaene(Ghent University), Tom Cattaert(University of Liège), Kristel Van Steen(Montefiore Hospital), Thibaut Van Zele(Ghent University), Frederic Acke(Age UK), Natalie De Ruyck(Age UK), Katrien Blomme(Ghent University), Ana R. Sousa(GlaxoSmithKline (United Kingdom)), Richard P. Marshall(GlaxoSmithKline (United Kingdom)), Claus Bachert(Ghent University)
Cited by 621Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis